BrainsWay (BWAY) Set to Announce Quarterly Earnings on Tuesday

BrainsWay (NASDAQ:BWAYGet Free Report) will be issuing its quarterly earnings data before the market opens on Tuesday, November 12th. Analysts expect the company to announce earnings of $0.01 per share for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link.

BrainsWay Stock Performance

Shares of BrainsWay stock opened at $10.86 on Monday. The company has a market capitalization of $181.12 million, a P/E ratio of 217.20 and a beta of 1.25. The company has a fifty day moving average of $9.06 and a 200 day moving average of $7.35. BrainsWay has a fifty-two week low of $3.78 and a fifty-two week high of $10.89.

Analyst Upgrades and Downgrades

BWAY has been the topic of several research analyst reports. HC Wainwright reiterated a “buy” rating and issued a $16.00 price target on shares of BrainsWay in a research note on Monday, October 21st. Northland Securities upped their target price on shares of BrainsWay from $11.00 to $12.50 and gave the company an “outperform” rating in a research report on Thursday, October 3rd.

Check Out Our Latest Stock Analysis on BrainsWay

BrainsWay Company Profile

(Get Free Report)

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases.

Featured Articles

Earnings History for BrainsWay (NASDAQ:BWAY)

Receive News & Ratings for BrainsWay Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BrainsWay and related companies with MarketBeat.com's FREE daily email newsletter.